| Trial ID: | L4257 |
| Source ID: | NCT01331317
|
| Associated Drug: |
Paricalcitol
|
| Title: |
Effect of a Vitamin D Analogue vs Placebo on p-NT-proBNP in Patients With Type 1 DM and Diabetic Nephropathy
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Cardiovascular Disease|Diabetic Nephropathy
|
| Interventions: |
DRUG: Paricalcitol
|
| Outcome Measures: |
Primary: Change in plasma NT-proBNP, 7 months | Secondary: Change in Glomerular Filtration Rate (GFR), 7 months|Change in Urinary Albumin Excretion Rate, 7 months
|
| Sponsor/Collaborators: |
Sponsor: Peter Rossing | Collaborators: Abbott
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
48
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2010-04
|
| Completion Date: |
2012-04
|
| Results First Posted: |
|
| Last Update Posted: |
2012-04-13
|
| Locations: |
Steno Diabetes Center A/S, Gentofte, 2400, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01331317
|
